Procept Biorobotics Valuation
| PRCT Stock | USD 76.02 2.82 3.58% |
At this time, the company appears to be undervalued. Procept Biorobotics Corp holds a recent Real Value of $84.78 per share. The prevailing price of the company is $76.02. Our model determines the value of Procept Biorobotics Corp from analyzing the company fundamentals such as Return On Equity of -0.37, operating margin of (0.38) %, and Shares Outstanding of 54.11 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Procept Biorobotics' price fluctuation is very steady at this time. Calculation of the real value of Procept Biorobotics Corp is based on 3 months time horizon. Increasing Procept Biorobotics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Procept Biorobotics' intrinsic value may or may not be the same as its current market price of 76.02, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 76.02 | Real 84.78 | Hype 75.85 | Naive 77.05 |
The intrinsic value of Procept Biorobotics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Procept Biorobotics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Procept Biorobotics Corp helps investors to forecast how Procept stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Procept Biorobotics more accurately as focusing exclusively on Procept Biorobotics' fundamentals will not take into account other important factors: Procept Biorobotics Total Value Analysis
Procept Biorobotics Corp is at this time forecasted to have valuation of 4 B with market capitalization of 4.11 B, debt of 79.2 M, and cash on hands of 269.81 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Procept Biorobotics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4 B | 4.11 B | 79.2 M | 269.81 M |
Procept Biorobotics Investor Information
About 88.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.95. Procept Biorobotics Corp had not issued any dividends in recent years. Based on the key indicators related to Procept Biorobotics' liquidity, profitability, solvency, and operating efficiency, Procept Biorobotics Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Procept Biorobotics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Procept Biorobotics has an asset utilization ratio of 33.65 percent. This implies that the Company is making $0.34 for each dollar of assets. An increasing asset utilization means that Procept Biorobotics Corp is more efficient with each dollar of assets it utilizes for everyday operations.Procept Biorobotics Ownership Allocation
Procept Biorobotics owns a total of 54.11 Million outstanding shares. The majority of Procept Biorobotics Corp outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Procept Biorobotics Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Procept Biorobotics. Please pay attention to any change in the institutional holdings of Procept Biorobotics Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Procept Biorobotics Profitability Analysis
The company reported the previous year's revenue of 136.19 M. Net Loss for the year was (105.9 M) with profit before overhead, payroll, taxes, and interest of 114.68 M.About Procept Biorobotics Valuation
The stock valuation mechanism determines Procept Biorobotics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Procept Biorobotics Corp based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Procept Biorobotics. We calculate exposure to Procept Biorobotics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Procept Biorobotics's related companies.PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. Procept Biorobotics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 234 people.
Procept Biorobotics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Procept Biorobotics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 47.3 M |
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.